RAGE biology, atherosclerosis and diabetes (Q37860348)

24 August 2017

1 reference

title

RAGE biology, atherosclerosis and diabetes (English)

1 reference

24 August 2017

1 reference

Drazenka Pongrac Barlovic

series ordinal

1

1 reference

24 August 2017

Aino Soro-Paavonen

series ordinal

2

1 reference

24 August 2017

Karin A M Jandeleit-Dahm

series ordinal

3

1 reference

24 August 2017

language of work or name

English

0 references

publication date

1 July 2011

1 reference

24 August 2017

1 reference

24 August 2017

121

1 reference

24 August 2017

43-55

1 reference

24 August 2017

2

1 reference

Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study.

24 August 2017

1 reference

https://api.crossref.org/works/10.1042%2FCS20100501

Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100501

Long-term follow-up after tight control of blood pressure in type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100501

Prevention of accelerated atherosclerosis by angiotensin-converting enzyme inhibition in diabetic apolipoprotein E-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100501

Why does diabetes increase atherosclerosis? I don't know!

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100501

Morphologic findings of coronary atherosclerotic plaques in diabetics: a postmortem study

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100501

Biochemistry and molecular cell biology of diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100501

Atherosclerosis — An Inflammatory Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100501

High glucose induces IL-1beta expression in human monocytes: mechanistic insights

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100501

Type 1 diabetes promotes disruption of advanced atherosclerotic lesions in LDL receptor-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100501

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100501

Endothelial dysfunction in insulin resistance and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100501

Cardiovascular risk continuum: implications of insulin resistance and diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100501

Circulating glycotoxins and dietary advanced glycation endproducts: two links to inflammatory response, oxidative stress, and aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100501

AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. I. The AGE concept.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100501

Recent progress in advanced glycation and diabetic vascular disease: role of advanced glycation end product receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100501

Advanced protein glycosylation in diabetes and aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100501

Confocal Raman microscopy can quantify advanced glycation end product (AGE) modifications in Bruch's membrane leading to accurate, nondestructive prediction of ocular aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100501

The glyoxalase system: new developments towards functional characterization of a metabolic pathway fundamental to biological life

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100501

Peptide mapping of human serum albumin modified minimally by methylglyoxal in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100501

N(epsilon)-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100501

Aminoguanidine prevents age-related arterial stiffening and cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100501

Alterations in renal mitochondrial respiration in response to the reactive oxoaldehyde methylglyoxal

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100501

Circulating high-molecular-weight RAGE ligands activate pathways implicated in the development of diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100501

Renal fate of circulating advanced glycated end products (AGE): evidence for reabsorption and catabolism of AGE-peptides by renal proximal tubular cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100501

Multiple levels of regulation determine the role of the receptor for AGE (RAGE) as common soil in inflammation, immune responses and diabetes mellitus and its complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100501

RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100501

Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-kappaB require the cytoplasmic domain of the receptor but different downstream signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100501

The biology of the receptor for advanced glycation end products and its ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100501

Increased proinflammatory endothelial response to S100A8/A9 after preactivation through advanced glycation end products

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100501

Binding of S100 proteins to RAGE: an update.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100501

Understanding RAGE, the receptor for advanced glycation end products

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100501

The extracellular region of the receptor for advanced glycation end products is composed of two independent structural units.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100501

RAGE: a novel biological and genetic marker for vascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100501

Alternative splicing of the murine receptor for advanced glycation end-products (RAGE) gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100501

Interaction of the RAGE cytoplasmic domain with diaphanous-1 is required for ligand-stimulated cellular migration through activation of Rac1 and Cdc42

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100501

Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100501

Receptor for advanced glycation end products is subjected to protein ectodomain shedding by metalloproteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100501

Soluble RAGE but not endogenous secretory RAGE is associated with albuminuria in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100501

Soluble forms of RAGE in human diseases: clinical and therapeutical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100501

Plasma levels of soluble receptor for advanced glycation end products and coronary artery disease in nondiabetic men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100501

Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100501

Loss of pain perception in diabetes is dependent on a receptor of the immunoglobulin superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100501

Activation of the receptor for advanced glycation end products triggers a p21(ras)-dependent mitogen-activated protein kinase pathway regulated by oxidant stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100501

RAGE-induced cytosolic ROS promote mitochondrial superoxide generation in diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100501

Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of dia

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100501

Receptor for advanced glycation end products (RAGE) deficiency attenuates the development of atherosclerosis in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100501

AGE/RAGE produces endothelial dysfunction in coronary arterioles in type 2 diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100501

Activation of the ROCK1 branch of the transforming growth factor-beta pathway contributes to RAGE-dependent acceleration of atherosclerosis in diabetic ApoE-null mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100501

Pathophysiology of advanced glycation end-products in renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100501

Vascular and inflammatory stresses mediate atherosclerosis via RAGE and its ligands in apoE-/- mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100501

Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100501

Advanced glycation end products and endothelial dysfunction in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100501

Regulation of endothelial nitric oxide synthase expression by albumin-derived advanced glycosylation end products

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100501

Endothelin 1 transcription is controlled by nuclear factor-kappaB in AGE-stimulated cultured endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100501

Advanced glycation end product (AGE)-mediated induction of tissue factor in cultured endothelial cells is dependent on RAGE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100501

Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100501

Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100501

Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy. Soluble receptor for advanced glycation end products blocks hyperpermeability in diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100501

Advanced glycation end products increase retinal vascular endothelial growth factor expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100501

Leukocyte-endothelial interaction is augmented by high glucose concentrations and hyperglycemia in a NF-kB-dependent fashion

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100501

Mechanistic Studies of Advanced Glycosylation End Product Inhibition by Aminoguanidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100501

Advanced glycation end products-induced gene expression of scavenger receptors in cultured human monocyte-derived macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100501

Advanced glycation end products depress function of endothelial progenitor cells via p38 and ERK 1/2 mitogen-activated protein kinase pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100501

Modification of enzymatic antioxidants in retinal microvascular cells by glucose or advanced glycation end products.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100501

Advanced glycation endproducts alter functions and promote apoptosis in endothelial progenitor cells through receptor for advanced glycation endproducts mediate overpression of cell oxidant stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100501

Endothelial receptor-mediated binding of glucose-modified albumin is associated with increased monolayer permeability and modulation of cell surface coagulant properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100501

Advanced glycation end products in diabetic patients with optimized glycaemic control and their effects on endothelial reactivity: possible implications in venous graft failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100501

Interactions between renin angiotensin system and advanced glycation in the kidney.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100501

Receptor for AGEs (RAGE) blockade may exert its renoprotective effects in patients with diabetic nephropathy via induction of the angiotensin II type 2 (AT2) receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100501

Advanced glycation end product interventions reduce diabetes-accelerated atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100501

A breaker of advanced glycation end products attenuates diabetes-induced myocardial structural changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100501

Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100501

RAGE blockade stabilizes established atherosclerosis in diabetic apolipoprotein E-null mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100501

RAGE mediates oxidized LDL-induced pro-inflammatory effects and atherosclerosis in non-diabetic LDL receptor-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100501

Central role of RAGE-dependent neointimal expansion in arterial restenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100501

Receptor for AGE (RAGE) mediates neointimal formation in response to arterial injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100501

Receptor for advanced glycation end products mediates inflammation and enhanced expression of tissue factor in vasculature of diabetic apolipoprotein E-null mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100501

RAGE modulates vascular inflammation and atherosclerosis in a murine model of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100501

Soluble receptor of advanced glycation end products levels are related to ischaemic aetiology and extent of coronary disease in chronic heart failure patients, independent of advanced glycation end products levels: New Roles for Soluble RAGE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100501

Association between circulating soluble receptor for advanced glycation end products and atherosclerosis: observations from the Dallas Heart Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100501

Association of polymorphism in the receptor for advanced glycation end products (RAGE) gene with circulating RAGE levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100501

High-Mobility Group Box 1 Activates Integrin-Dependent Homing of Endothelial Progenitor Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100501

Lack of the Antioxidant Enzyme Glutathione Peroxidase-1 Accelerates Atherosclerosis in Diabetic Apolipoprotein E–Deficient Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100501

21 January 2018

Identifiers

DOI

10.1042/CS20100501

1 reference

24 August 2017

1 reference